APA (7th ed.) Citation

Delaunois, A., Mathy, F., Cornet, M., Gryshkova, V., Korlowski, C., Bonfitto, F., . . . Valentin, J. (2023). Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study. Pharmacology Research & Perspectives, 11(1), 1. https://doi.org/10.1002/prp2.1059

Chicago Style (17th ed.) Citation

Delaunois, Annie, et al. "Testing the Nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) Paradigm with an Established Anti‐seizure Medication: Levetiracetam Case Study." Pharmacology Research & Perspectives 11, no. 1 (2023): 1. https://doi.org/10.1002/prp2.1059.

MLA (9th ed.) Citation

Delaunois, Annie, et al. "Testing the Nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) Paradigm with an Established Anti‐seizure Medication: Levetiracetam Case Study." Pharmacology Research & Perspectives, vol. 11, no. 1, 2023, p. 1, https://doi.org/10.1002/prp2.1059.